Spectrum Pharmaceuticals, Inc. Announces Date and Time for Third Quarter 2010 Corporate Update Conference Call

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced the date and time for its third quarter 2010 corporate update and pipeline review conference call.

MORE ON THIS TOPIC